LEXARIA BIOSCIENCE CORP. Operating Lease, Lease Income, Lease Payments
LEXARIA BIOSCIENCE CORP. (LEXX) reported Operating Lease, Lease Income, Lease Payments of $26.88 thousand for the 9-month period ending 2024-05-31, per its 10-Q filed 2024-07-12.
Discontinued › Income Statement › Other Income
us-gaap:OperatingLeaseLeaseIncomeLeasePayments · last filed 2024-07-12
- LEXARIA BIOSCIENCE CORP. operating lease, lease income, lease payments for the quarter ending 2024-05-31 was $8.96K, a 32.20% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. operating lease, lease income, lease payments for the quarter ending 2024-02-29 was $8.96K.
- LEXARIA BIOSCIENCE CORP. operating lease, lease income, lease payments for the quarter ending 2023-11-30 was $8.96K, a 80.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. operating lease, lease income, lease payments for the quarter ending 2023-08-31 was $11.20K, a 0.00% change year-over-year.
- LEXARIA BIOSCIENCE CORP. operating lease, lease income, lease payments for fiscal 2022 was $44.60K, a 1.48% increase from fiscal 2021.
- LEXARIA BIOSCIENCE CORP. operating lease, lease income, lease payments for fiscal 2021 was $43.95K, a 0.43% increase from fiscal 2020.
- LEXARIA BIOSCIENCE CORP. operating lease, lease income, lease payments for fiscal 2020 was $43.76K.
| Period end | Operating Lease, Lease Income, Lease Payments 3 month | Operating Lease, Lease Income, Lease Payments 3 month as first filed | Operating Lease, Lease Income, Lease Payments 6 month | Operating Lease, Lease Income, Lease Payments 9 month | Operating Lease, Lease Income, Lease Payments 12 month |
|---|---|---|---|---|---|
| 2024-05-31 | $8.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-07-12 | $17.92K derived: sum of 2 quarters · filed 2024-07-12 | $26.88K 10-Q · filed 2024-07-12 | $38.09K derived: sum of 4 quarters · filed 2024-07-12 | |
| 2024-02-29 | $8.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-04-09 | $17.92K 10-Q · filed 2024-04-09 | $29.13K derived: sum of 3 quarters · filed 2024-07-12 | $42.34K derived: sum of 4 quarters · filed 2024-07-12 | |
| 2023-11-30 | $8.96K 10-Q · filed 2024-01-12 | $20.17K derived: sum of 2 quarters · filed 2024-07-12 | $33.38K derived: sum of 3 quarters · filed 2024-07-12 | $8.96K derived: sum of 4 quarters · filed 2024-07-12 | |
| 2023-08-31 | $11.20K derived: 10-Q 12 month − 10-Q 9 month · filed 2024-07-12 | $24.42K derived: sum of 2 quarters · filed 2024-07-12 | $0.00 derived: sum of 3 quarters · filed 2024-07-12 | $44.81K 10-Q · filed 2024-07-12 | |
| 2023-05-31 | $13.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-07-14 | -$11.20K derived: sum of 2 quarters · filed 2023-07-14 | $33.61K 10-Q · filed 2023-07-14 | $44.81K derived: sum of 4 quarters · filed 2024-01-12 | |
| 2023-02-28 | -$24.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-04-14 | $20.40K 10-Q · filed 2023-04-14 | $31.60K derived: sum of 3 quarters · filed 2024-01-12 | $42.80K derived: sum of 4 quarters · filed 2024-01-12 | |
| 2022-11-30 | $44.81K 10-Q · filed 2024-01-12 | $11.20K 10-Q · filed 2023-01-17 | $56.02K derived: sum of 2 quarters · filed 2024-01-12 | $67.22K derived: sum of 3 quarters · filed 2024-01-12 | $78.43K derived: sum of 4 quarters · filed 2024-01-12 |
| 2022-08-31 | $11.20K derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-20 | $22.41K derived: sum of 2 quarters · filed 2023-11-20 | $33.61K derived: sum of 3 quarters · filed 2023-11-20 | $44.60K 10-K · filed 2023-11-20 | |
| 2022-05-31 | $11.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-07-14 | $22.41K derived: sum of 2 quarters · filed 2022-07-14 | $33.40K 10-Q · filed 2022-07-14 | $66.40K derived: sum of 4 quarters · filed 2022-11-28 | |
| 2022-02-28 | $11.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-04-11 | $22.19K 10-Q · filed 2022-04-11 | $55.19K derived: sum of 3 quarters · filed 2022-11-28 | ||
| 2021-11-30 | $10.99K 10-Q · filed 2022-01-14 | $43.99K derived: sum of 2 quarters · filed 2022-11-28 | |||
| 2021-08-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | $43.95K 10-K · filed 2022-11-28 | |||
| 2021-05-31 | $10.95K 10-Q · filed 2021-07-15 | ||||
| 2020-11-30 | -$10.95K 10-Q · filed 2021-01-14 | ||||
| 2020-08-31 | $43.76K 10-K · filed 2021-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |